A Two-Part Intervention to Target Cardiovascular Health
Autism Research Consortium on Physical Health: A Two-Part Intervention to Target Cardiovascular Health
2 other identifiers
interventional
130
0 countries
N/A
Brief Summary
Obesity is one of the most common health conditions among autistic young people and its prevalence rises at faster rates for autistic-relative to non-autistic-individuals. This places them at heightened risk for cardiovascular disease (CVD) and mortality before they enter adulthood. Studies have identified three key contributing factors to CVD outcomes in autistic individuals: unhealthy lifestyle behaviors, Adverse Childhood Experiences (ACEs), and chronic stress. This study will explore the effectiveness of two CVD-focused primary care interventions for autistic individuals (ages 9-26): (1) lifestyle medicine consultations tailored towards supporting health-promoting behaviors; and (2) a Cognitive Behavioral Therapy (CBT) intervention tailored towards addressing chronic stress that contributes to excess weight and maladaptive eating behaviors and results in obesity and CVD. Participants and their caregivers will be randomly placed into either the Lifestyle Medicine Group, CBT Group, or combined Lifestyle Medicine with CBT Group. Participants will respond to questionnaires and surveys measuring lifestyle habits, stress, and psychological risk factors at their first visit, 6-month visit, and 3 months post-intervention visit. Over the course of 6 months, participants will attend virtual sessions (up to three times a month) in accordance with their intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
June 29, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
June 29, 2026
June 1, 2026
2.1 years
April 13, 2026
June 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Behavior Assessment System for Children: Third Edition (BASC-3)
A series of instruments designed to help aid in the diagnosis and treatment of children, adolescents, and young adults between the ages of 2 and 25 - captures self- and/or caregiver reported psychological distress.
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
American College of Lifestyle Medicine (ACLM) Nutrition in Action Diet Screener
Self- and/or caregiver reported diet, physical activity, sleep, stress, and motivation to change.
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Adverse Childhood Experiences Screener (PEARLS/ACEs)
Captures adverse childhood experiences.
Administered at Baseline
General Nutrition Knowledge Questionnaire (GNKQ)
Captures general knowledge of nutrition and food groups.
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Project EAT-IV Survey
Self- and/or caregiver reported diet, physical activity, sleep, and stress.
Administered at Baseline
Participant and Caregiver Survey
Addresses participant and caregiver experience in the study - captures acceptability and feasibility of intervention.
Administered at final intervention visit (6-month mark).
Childhood Autism Rating Scale: Second Edition (CARS-2)
Identifies autism spectrum disorder (ASD) in children and the severity of their symptoms.
Administered at Baseline
ASD DSM-5 Checklist
Captures diagnostic criterion from clinicians when used to diagnose Autism Spectrum Disorder.
Administered at Baseline
Vineland Adaptive Behavioral Scales: Third Edition (Vineland-III)
Used to measure adaptive behaviors and aid in the diagnosis of intellectual and developmental disabilities.
Administered at Baseline
Secondary Outcomes (4)
Cardiovascular disease (CVD) indicators
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Cardiovascular disease (CVD) indicators
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Cardiovascular disease (CVD) indicators
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Cardiovascular disease (CVD) indicators
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
Study Arms (3)
1) Lifestyle Medicine Group
ACTIVE COMPARATORThis group will receive the Lifestyle Medicine Intervention. This intervention is comprised of 6 monthly lifestyle medicine consultations with a health coach.
Cognitive Behavioral Therapy (CBT) Group
ACTIVE COMPARATORThis group will receive the CBT Intervention. This intervention is comprised of 12, twice-monthly CBT sessions over the span of 6 months.
Lifestyle Medicine with CBT Group
ACTIVE COMPARATORThis group will receive both the Lifestyle Medicine and CBT Interventions.
Interventions
The intervention is a series of lifestyle medicine consultations.
The intervention is a series of CBT sessions.
Receives both Lifestyle Medicine and CBT interventions
Eligibility Criteria
You may qualify if:
- Have a diagnosis of autism or be told by a healthcare provider that you have autism
- Be between the ages of 9 and 26
- Have a BMI greater than the 84th percentile
- English speaking
You may not qualify if:
- Children younger than 9 years of age
- Adults older than 26 years of age
- Individuals without a diagnosis of autism
- Individuals with a BMI less than the 84th percentile
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alice Kuo, MD, PhD
University of California, Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chief
Study Record Dates
First Submitted
April 13, 2026
First Posted
June 29, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
July 30, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
June 29, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share